Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Sexual disorders in men with multiple sclerosis: Evaluation and management.
Fingolimod in a patient with heart failure on the background of pulmonary arterial hypertension and coronary artery disease.
Pregnancy and fetal outcomes following natalizumab exposure in pregnancy. A prospective, controlled observational study.
An assay to quantify species-specific anti-JC virus antibody levels in MS patients.
Oral and craniofacial manifestations of multiple sclerosis: implications for the oral health care provider.
FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS.
The antibody response to Epstein-Barr virions is altered in multiple sclerosis.
Multiple sclerosis fatigue relief by bilateral somatosensory cortex neuromodulation.
Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases.
Multiple sclerosis and seizures: incidence and prevalence over 40 years.
Possible role of interleukin-17 in a prime/challenge model of multiple sclerosis.
Radiologically isolated syndrome - incidental magnetic resonance imaging findings suggestive of multiple sclerosis, a systematic review.
"Disease modifying nutricals" for multiple sclerosis.
Fatigue in multiple sclerosis: relationship with disease duration, physical disability, disease pattern, age and sex.
2-photon imaging of phagocyte-mediated T cell activation in the CNS.
Applying an Open-Source Segmentation Algorithm to Different OCT Devices in Multiple Sclerosis Patients and Healthy Controls: Implications for Clinical Trials.
NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis.
Uveitis as a prognostic factor in multiple sclerosis.
Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen.
Markers of oxidative stress in plasma and saliva in patients with multiple sclerosis.
Merck Serono and Opexa Therapeutics Enter into Option and License Agreement for Development of Tcelna™ (imilecleucel-T) for Treatment of Multiple Sclerosis
Self-reported health promotion and disability progression in multiple sclerosis.
Incidence of multiple sclerosis in multiple racial and ethnic groups.
Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia.
T Cell Epitope Mapping of JC Polyoma Virus-Encoded Proteome Reveals Reduced T Cell Responses in HLA-DRB1*04:01+ Donors.

Pages